Evidence map›Paper›PMID 41245753›Full record

ArticleChemical science2026

Topology engineering of COFs

Jiaxing Xiong, Qi An, Hao Xiang, Yu Zhou, Yuan Zhang, WenJing Chen, Boxian Ren, Shixiong Wang, Huiping Bai, Hong Guo and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiaxing XiongSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Qi AnInternational Joint Research Center for Advanced Energy Materials of Yunnan Province, School of Materials and Energy, Yunnan University Kunming 650091 China.
Hao XiangSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Yu ZhouSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Yuan ZhangSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
WenJing ChenSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Boxian RenSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Shixiong WangSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.
Huiping BaiInternational Joint Research Center for Advanced Energy Materials of Yunnan Province, School of Materials and Energy, Yunnan University Kunming 650091 China.
Hong GuoInternational Joint Research Center for Advanced Energy Materials of Yunnan Province, School of Materials and Energy, Yunnan University Kunming 650091 China.ORCID https://orcid.org/0000-0001-5693-2980
Xiangjun YangSchool of Chemical Science and Technology, Yunnan University Kunming 650091 China.ORCID https://orcid.org/0000-0002-0231-0243

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing cost-effective adsorbents for gold recovery from electronic waste (e-waste) is crucial. Here, we report a dimensional engineering strategy to fabricate covalent organic framework (COF) heterostructures with locally interconnected dimensions, enabling highly efficient host-guest recognition of Au(iii) in e-waste leachates. The heterostructures feature local interconnections between 2D and 1D units, introducing additional electron transport pathways. This structural innovation optimizes the electron transport kinetics essential for adsorptive redox reactions. Experimental results demonstrate that the locally interconnected dimensional architecture of TpaIda-2DCOF achieves a static saturation adsorption capacity of 3601 mg g

Identifiers

PMID41245753
PMCPMC12616540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.